Business, energy, technology, markets and global industry news from Business News Today

Frontiers in Gastroenterology

PharmaDeviceNews Frontiers in Gastroenterology
Gemelli Biotech’s IBS-Smart and Trio-Smart testing was linked to lower use of selected diagnostic procedures and lower captured diagnostic costs in a real-world irritable bowel syndrome study. Representative image.
Medical Devices & Diagnostics

Gemelli Biotech IBS-Smart study finds lower diagnostic costs in patients with suspected IBS

Gemelli Biotech’s IBS-Smart and Trio-Smart were linked to lower captured diagnostic costs in a 219-patient IBS study, but causality remains unproven.

Read More